P330: TARGETING BTN2A1 BY A UNIQUE ACTIVATING MAB IMPROVES ANTI-TUMOR FUNCTIONS OF VΓ9VΔ2 T CELLS. (23rd June 2022) - Le Floch, A.-C.; Imbert, C.; de Gassart, A.; Le Roy, A.; Gorvel, L.; Vey, N.; Anastasio, A.; Briantais, A.; Boucherit, N.; Cano, C. E.; Olive, D.